Table 2

Outcomes within 30 days of diagnosis

OutcomesTotal (n=40)HBO2
(n=20)
Control (n=20)P valueEffect size (95% CI)
Days to normalisation*5.0 (3.0; 9.0)3.0 (1.0; 4.5)9.0 (5.5; 12.5)<0.010HR 6.9 (2.9 to 16.2)
SpO2 ≥93% at 3 days, n (%)12 (30)11 (55)1 (8)0.001OR 23.2 (1.6 to 329.6)
SpO2 ≥93% at 5 days, n (%)27 (68)19 (95)8 (40)<0.001OR 28.5 (1.8 to 447.4)
SpO2 ≥93% at 10 days, n (%)33 (83)20 (100)13(65)0.004
SpO2 ≥93% at 15 days, n (%)36 (90)20 (100)16 (80)0.106
Acute respiratory distress, n (%)4 (10)1 (5)3 (15)0.605OR 0.3 (0.0 to 3.4)
Mechanical ventilation, n (%)4 (10)1 (5)3 (15)0.605OR 0.3 (0.0 to 3.4)
Death, n (%)2 (5)1 (5)1 (5)1.000OR 1.0 (0.1 to 17.8)
  • * Median (25th percentile; 75th percentile).

  • SpO2, oxygen saturation.